The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated in a drug used to treat pulmonary fibrosis. The researchers show that these nanoparticles are highly capable of remaining trapped in the diseased tissue after being administered via the pulmonary pathway. This allows the doses of antifibrotic medication to be cut, and thus reduces the potential side effects associated with conventional therapies. Tests carried out on mice displayed a therapeutic effect on pulmonary fibrosis.
The study, published in Advanced Healthcare Materials by the Molecular and Functional Biomarkers group at CIC biomaGUNE, presents a simple, automated, and reproducible synthesis method that ensures effective drug encapsulation, appropriate distribution by particle size, and high stability by means of microfluidics, a technique that allows fluids to be managed at microscopic scale with great precision.
Pulmonary fibrosis is a relatively common chronic disease in which lung tissue forms scars in an uncontrolled, progressive way. The most common risk factors include smoking, occupational exposure to dust and chemicals, exposure to drugs such as chemotherapy or radiotherapy, and viral diseases such as COVID-19. This thickened, stiff tissue prevents the lungs from functioning properly, thus making breathing progressively more difficult. Conventional treatment for pulmonary fibrosis (administered orally) frequently has adverse effects, so there is great interest in improving the treatment.
Although administering drugs via inhalation makes the targeted treatment of the lungs possible, their clinical efficacy is often limited by inflammation, uneven distribution, and physiological barriers. “To reduce the side effects caused by drugs used to treat pulmonary fibrosis, the best thing is to target the diseased tissue directly,” explained Dr. Susana Carregal, an Ikerbasque Research Fellow.
“Inhalation is a very direct way of delivering medicine to the lungs. However, as the lungs are designed to protect themselves against inhaled pathogens, the very mechanisms that help defend the body also make this type of administration through inhalation more complicated.”
The power of mimicry
Currently, to ensure that these types of therapies work effectively, there is extensive research that focuses on finding ways of evading the immune system, in other words, so that the lungs cannot recognize the drugs as pathogens or foreign substances, thereby allowing them to reach their target. In this respect, the research team led by Dr. Carregal has developed a biomimetic platform based on pulmonary surfactant nanoparticles “which preserves the native proteins and lipids of the surfactant and its biophysical functionality, thereby improving pulmonary delivery,” said Dr. Carregal, the lead researcher in the study.
“The lung is filled with pulmonary surfactant; this is the interface where the exchange between air and fluid takes place,” she explained. “Encapsulating drugs designed to treat lung diseases in pulmonary surfactant can improve distribution throughout the lung, due to its surface properties. In other words, using an endogenous material can help to ensure that, when administered by inhalation, the drug is distributed more effectively in the lung.”
The CIC biomaGUNE research team found that “90% of the administered nanomedicine is retained in the lungs in mouse models. Retention is very high, and this means that, with this treatment, the amount of drug reaching the liver is much lower than with conventional treatments, thereby reducing the side effects,” pointed out Carregal. It is important for a drug to act only where it should, in order to reduce the dose administered as well as the side effects.
The synthesis method developed at CIC biomaGUNE has the potential to drive forward the use of inhaled medicines. “The synthesis of these nanoparticles has been greatly simplified and can help standardize the product, as it produces materials or nanomedicines with a highly controlled size and direct encapsulation of the drug. It is a highly homogeneous and reproducible system. It opens up new avenues for developing inhaled treatments for lung diseases,” said Dr. Carregal.
Publication details
Laura Fernández‐Méndez et al, Pulmonary Surfactant Nanoparticles for Lung‐Targeted and Dose‐Efficient Delivery, Advanced Healthcare Materials (2026). DOI: 10.1002/adhm.202505871
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
